AMIX — Autonomix Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1617867 ·
Last close
$1.08
Market Cap
$2.21M
52W High
$24.68
52W Low
$0.93
ADV30
2,549,898
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -3,177,000 | -3,126,000 | 8,195,000 | 7,692,000 | 1,254,000 |
| Jun 2026 | 0 | — | -2,770,000 | -2,728,000 | 3,980,000 | 3,460,000 | 818,000 |
| Mar 2026 | 0 | — | -2,737,000 | -2,666,000 | 7,600,000 | 7,004,000 | 1,705,000 |
| Dec 2025 | 0 | — | -3,343,000 | -3,261,000 | 10,211,000 | 9,934,000 | 1,650,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,222,000
Investing CF
$-10,000
Financing CF
$8,103,000
CapEx
$-7,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-64.25
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-69,822,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-16,148,000
Pretax Income TTM
$-16,106,000
Interest Exp TTM
$0
Analysts
2
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -17,034,000 | -16,715,000 | 7,600,000 | 1,705,000 | 5,895,000 | -12,282,000 |
| Mar 2025 | 0 | -11,588,000 | -11,410,000 | 9,806,000 | 1,707,000 | 8,099,000 | -8,258,000 |
| Mar 2024 | 0 | -7,474,000 | -15,426,000 | 9,407,000 | 1,779,000 | 7,628,000 | -6,648,000 |
| Mar 2023 | 0 | -1,990,000 | -1,990,000 | 865,000 | 221,000 | 644,000 | -1,854,000 |
TTM Snapshot
Revenues TTM
$277,000
NetIncome TTM
$-16,106,000
OpCashFlow TTM
—
Assets (Latest)
$3,980,000
Forward EPS
$-7.40
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NUWE | Nuwellis, Inc. | $2.22M | $4.10 | — |
| CODX | Co-Diagnostics, Inc. | $2.06M | $0.20 | — |
| BJDX | Bluejay Diagnostics, Inc. | $2.41M | $2.15 | — |
| DROR | Dror Ortho-Design, Inc. | $2.44M | $0.00 | — |
| NXL | Nexalin Technology, Inc. | $1.85M | $1.50 | — |
News headlines (Yahoo Finance, 1h cache)
Autonomix Highlights Renal Denervation Strategy and Vision for Illuminating the Nervous System at TCT 2026
2026-11-12 13:30 · Yahoo
Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology
2026-11-10 19:30 · Yahoo
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
2026-10-02 12:05 · Yahoo
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
2026-09-30 12:30 · Yahoo
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
2026-09-24 12:30 · Yahoo
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
2026-09-16 12:30 · Yahoo
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
2026-09-01 12:30 · Yahoo
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
2026-08-26 12:30 · Yahoo
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
2026-08-25 01:06 · Yahoo
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
2026-08-12 12:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.